-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Marinus Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2022 to Q2 2023.
- Marinus Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was -$1.54M.
- Marinus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$1.54M, a 145% decline from 2022.
Income Tax Expense (Benefit), Quarterly (USD)